Other Content

Latest News

New ISAC President / ...

Prof. Andreas Voss announced as ISAC's new President!

Read More
That's a wrap!

The 31st ICC - 4th GCCMID has now concluded!

Read More

The following are a list of publications written under the auspices of ISAC:

Influenza_Poster.pdf
Not sick enough to worry? "Flu-like" symptoms and work-related behaviour among healthcare workers and other professionals worldwide. 
Ermira Tartari*,Katja Saris*, Nikki Kenters, Kalisvar Marimuthu, Andreas Widmer, Peter Collignon, Vincent Cheng, Shuk Ching Wong, Tom Gottlieb, Eli Perencevich, Paul Tambyah, Benedetta Allegranzi, Angela Dramowski, Michael Edmond, Members of the ISAC-IPC working group, Andreas Voss On behalf of: ISAC, Infection Prevention and Control (IPC) Working Group
Control of Candida auris in healthcare institutions: outcome of an ISAC expert meeting
Kenters N, Kiernan M, Chowdhary A et al.
Int J Antimicrob Agents. Aug 2019 [Epub ahead of print]
Hot Topics on Vertebral Osteomyelitis from the International Society of Antimicrobial Chemotherapy.
Saeed K, Esposito S, Ascione T et al
Int J Antimicrob Agents. 2019 June [Epub ahead of print]
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.
Jean SS, Gould IM, Lee WS et al.
Drugs. 2019 May;79(7):705-714
An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC).
Saeed K, Bal AM, Gould IM et al.
Int J Antimicrob Agents. 2019 Jan;53(1):9-15
Hot topics in necrotising skin and soft tissue infections.
Saeed K, Esposito S, Gould I et al.
Int J Antimicrob Agents. 2018 Jul;52(1):1-10
Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy.
Saeed K, Gould I, Esposito S et al.
Int J Antimicrob Agents. 2018 Jan;51(1):16-25
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Bal AM, David MZ, Garau J et al .
J Glob Antimicrob Resist. 2017 Sep;10:295-303
Prosthetic joints: shining lights on challenging blind spots.
Saeed K, Dryden M, Bassetti M et al.
Int J Antimicrob Agents. 2017 Feb;49(2):153-161
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
Purrello SM, Garau J, Giamarellos E et al.
J Glob Antimicrob Resist. 2016 Dec;7:178-186
Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: Blurring of the traditional definitions.
Bal AM, Coombs GW, Holden MTG et al.
J Glob Antimicrob Resist. 2016 Sep;6:95-101
Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy.
Levy Hara G, Kanj SS, Pagani L et al.
Int J Antimicrob Agents. 2016 Sep;48(3):239-46
Hot topics in the diagnosis and management of skin and soft-tissue infections.
Esposito S, Bassetti M, Bonnet E et al.
Int J Antimicrob Agents. 2016 Jul;48(1):19-26
Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals. 
Larsen J, David MZ, Vos MC et al.
J Glob Antimicrob Resist. 2014 Dec;2(4):260-268
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?
Edwards B, Andini R, Esposito S et al.
J Glob Antimicrob Resist. 2014 Sep;2(3):133-140
Meticillin-resistant Staphylococcus aureus (MRSA) update: New insights into bacterial adaptation and therapeutic targets.
Purrello SM, Daum RS, Edwards GF et al.
J Glob Antimicrob Resist. 2014 Jun;2(2):61-69
MDRO Beijing Consensus Meeting Report: Global burden of multidrug-resistant organisms' current antimicrobial resistance problems in Asia-Pacific.
Gould IM, Wang GQ, Wu JJ et al.
J Glob Antimicrob Resist. 2014 Mar;2(1):7-9
Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?
Bal AM, Garau J, Gould IM et al.
J Glob Antimicrob Resist. 2013 Mar;1(1):23-30
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.
Gould IM, David MZ, Esposito S et al.
Int J Antimicrob Agents. 2012 Feb;39(2):96-104
Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods.
Stefani S, Chung DR, Lindsay JA et al.
Int J Antimicrob Agents. 2012 Apr;39(4):273-82
Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA).
Skov R, Christiansen K, Dancer SJ et al.
Int J Antimicrob Agents. 2012 Mar;39(3):193-200
"Ten Commandments" for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient Setting.
Levy-Hara G, Amábile-Cuevas CF, Gould I et al.
Front Microbiol. 2011 Nov 24;2:230
Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy.
Esposito S, Bassetti M, Borre S et al.
J Chemother. 2011 Oct;23(5):251-62
Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation.
Cookson B, Bonten MJ, Mackenzie FM et al.
Int J Antimicrob Agents. 2011 Mar;37(3):195-201
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Gould IM, Cauda R, Esposito S et al.
Int J Antimicrob Agents. 2011 Mar;37(3):202-9